Quantrx Biomedical Corp (QTXB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6 | 55 | 130 | 322 | 863 |
| TOTAL | $6 | $55 | $137 | $360 | $891 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 0 | 222 | 500 |
| TOTAL | $N/A | $N/A | $N/A | $222 | $500 |
| Total Assets | $6 | $55 | $137 | $582 | $1,391 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10 | 16 | 62 | 56 | 168 |
| Accrued Expenses | 1,068 | 866 | 665 | 509 | 27 |
| TOTAL | $2,647 | $2,437 | $2,266 | $2,088 | $2,140 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,647 | $2,437 | $2,266 | $2,088 | $2,140 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,696 | 78,696 | 78,696 | 78,696 | 78,696 |
| Common Shares | 796 | 796 | 796 | 796 | 796 |
| Retained earnings | -52,375 | -52,115 | -51,862 | -51,240 | -50,504 |
| TOTAL | $-2,641 | $-2,381 | $-2,128 | $-1,506 | $-750 |
| Total Liabilities And Equity | $6 | $55 | $137 | $582 | $1,391 |